Transplacental Genetic Immunization After Intravenous Delivery of Plasmid DNA to Pregnant Mice

  • Okuda K
  • Xin K
  • Haruki A
  • et al.
22Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A number of factors influence the development of tolerance, including the nature, concentration, and mode of Ag presentation to the immune system, as well as the age of the host. The studies were conducted to determine whether immunizing pregnant mice with liposome-encapsulated DNA vaccines had an effect on the immune status of their offspring. Two different plasmids (encoding Ags from HIV-1 and influenza virus) were administered i.v. to pregnant mice. We examined the uptake of plasmid DNA by the fetuses until the 21st postcoital day, but little such transfer occurred in early pregnancy. At 9.5 days postconception with cationic liposomes, injected plasmid was present in the tissues of the fetus, consistent with transplacental transfer. When the offspring of vaccinated dams were immunized with DNA vaccine, they mounted stronger Ag-specific immune responses than controls, and were protected against challenge by homologous influenza virus after vaccination. Moreover, such immune responses were strong in the offspring of mothers injected with DNA plasmid 9.5 days after coitus. These results suggest that DNA-vaccinated mothers confer the Ag-specific immunity to their progeny.

Cite

CITATION STYLE

APA

Okuda, K., Xin, K.-Q., Haruki, A., Kawamoto, S., Kojima, Y., Hirahara, F., … Hamajima, K. (2001). Transplacental Genetic Immunization After Intravenous Delivery of Plasmid DNA to Pregnant Mice. The Journal of Immunology, 167(9), 5478–5484. https://doi.org/10.4049/jimmunol.167.9.5478

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free